Arrow-right Camera

The Spokesman-Review Newspaper The Spokesman-Review

Monday, October 14, 2019  Spokane, Washington  Est. May 19, 1883
Fog 39° Fog


Everything tagged

Sort by:

Stories tagged: drug prices

Tom Trail: Idahoans need relief from Rx greed

For too long, drug companies have been price gouging seniors and hardworking Americans.

Future is in doubt for cheaper versions of biologic drugs

Sales of biosimilars, cheaper near-copies of pricey biologic drugs, have been so limited in the U.S. that their future is in doubt.

Group with consumer-friendly vibe pushes drugmakers’ message

As Congress and President Donald Trump’s administration aim to lower prescription drug costs, outside groups like the Alliance for Patient Access are seeking to sway the outcome. But not all …

Liberals dare Trump to back their bills lowering drug prices

Challenging President Donald Trump to make good on his pledge to cut prescription drug prices, congressional liberals proposed legislation Thursday to bring U.S. prices in line with the much lower …

Froma Harrop: Forget about cheaper drugs on Trump’s watch

President Trump’s plan for lowering Medicare drug costs is good, even cutting-edge. As Democrats successfully campaign on health care, Trump has come back with a proposal that could save Medicare …

Trump signs bills to help patients stop overpaying for drugs

Insurers will no longer be able to bar pharmacists from telling consumers when paying cash would be cheaper than using insurance for their prescriptions, as a result of bills signed …

UPDATED: Fri., May 11, 2018, 10:10 p.m.

Trump’s prescription to reduce drug prices takes small steps

President Donald Trump’s long-awaited plan to bring down drug prices, unveiled Friday, will mostly spare the pharmaceutical industry he previously accused of “getting away with murder” and instead focus on …

UPDATED: Tue., Jan. 9, 2018, 10:14 a.m.

Trump health pick wary of government drug price negotiations

President Donald Trump’s pick for health secretary said Tuesday he’s wary of a broad government role in negotiating prescription drug prices, arguing that it may lead to reduced access for …

Generic-drugs firms under U.S. probe

U.S. prosecutors are examining the prices of skin treatments made by Perrigo Co. and a handful of other companies as part of a sweeping criminal investigation into possible collusion in …

Tough talk won’t lower drug prices

If prices don’t come down, and quickly, Trump should back up his tough talk with action.

Trump calls drug pricing ‘astronomical’ and promises changes

President Donald Trump told drugmakers at a White House meeting Tuesday they were charging too much and promised to get better bargains for government health programs, in addition to finding …

Albert R. Hunt: Trump could make headway on drug prices

There are arguments over the merits and effects, but the politics are clear cut. In a Kaiser Foundation poll last autumn, the public, by 82 percent to 17 percent, favored …

Secret rebates erode drugmaker revenue, industry study says

Branded drug companies’ share of total U.S. spending on their products is declining, in part because of an increase in secret rebates paid to middlemen, according to an analysis sponsored …

Consumer Confidential: Insulin price hikes aren’t sweet

A key feature of Republican plans to replace Obamacare is allowing market forces to boost innovation and competition among health care providers. “Unleashing the power of choice and competition is …

Shkreli says ‘of course’ he’d raise drug price again

Outspoken former pharmaceutical executive Martin Shkreli said the national outrage over drug pricing was blown out of proportion and heightened by the U.S. presidential election, although he conceded he could …

Senators urge action to block drastic drug price hikes

Angered by skyrocketing drug prices, a pair of senators on Wednesday urged Congress to block companies from cornering the market on old, off-patent drugs.

Pharmaceutical industry gearing up to defend drug prices

The skyrocketing costs of prescription drugs has been noticeably absent from discussion in the presidential debates – even as bipartisan anger about price gouging has united Congress. But the trade …

Drug industry group starts ad campaign to push back on pricing

A top pharmaceutical lobbying group is launching an ad campaign to defend drugmakers that have been under fire for their pricing practices.

Mylan launching cheaper, generic version of EpiPen

Mylan will start selling a cheaper version of its EpiPen after absorbing waves of criticism over a list price for the emergency allergy treatment that has grown to $608 for …

Insider Q&A: A model for more rational drug prices

Rising drug prices are creating anxiety for patients, politicians and physicians across the country, with little relief in sight.

Dr. Zorba Paster: You’re right to be angry about drug pricing

Don’t have to buy costly prescription – as long as you don’t touch it.

Consumer Confidential: In search of fair drug prices

When CVS Health in February began taking over pharmacy operations at more than 1,600 Target stores, CVS Pharmacy President Helena Foulkes called the changeover “an important milestone.” “Our heart is …

Drug distribution becomes weapon to block competition

The same strategy that Martin Shkreli used to get away with a 5,000-percent price increase on an old drug is used by many other drugmakers to maintain sky-high prices on …